Vixotrigine characterization
1 min read

Vixotrigine (Raxatrigine) has been developed as an analgesic to treat sciatica and trigeminal neuralgia.
In a study published in Molecular Pharmacology this month, BIOGEN, NEUROSERVICE and Charles River Laborarories have further investigated and characterized the targets and mechanisms of action of Vixotrigine by performing Patch Clamp recordings of human sodium channels in recombinant cell lines and of cultured rodent sensory neurons.

Read more in the joint publication on Molecular Pharmacology
Related scientific posts
View all- Cell ElectrophysiologyWhich CRO Offers the Strongest HD-MEA Assay for DRG Pain Pharmacology?16.10.2026
- Addiction StudiesModeling the Long Shadow of Opioid Craving: What Cue-Induced Reinstatement Tells Us About Relapse28.09.2026
- Brain Slice electrophysiologyHow Long Should You Wait Before Trusting a Gramicidin-Perforated Patch? Characterizing E-GABA Assay Readiness in Rat Cortical Neurons26.08.2026
